203 related articles for article (PubMed ID: 35381024)
1. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries.
Kerzner M; De AK; Yee R; Keating R; Djomand G; Stash S; Rana S; Kimmel A; Eakle R; Klucking S; Patel P;
PLoS One; 2022; 17(4):e0266280. PubMed ID: 35381024
[TBL] [Abstract][Full Text] [Related]
2. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
[TBL] [Abstract][Full Text] [Related]
3. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
Medina-Marino A; Bezuidenhout D; Ngwepe P; Bezuidenhout C; Facente SN; Mabandla S; Hosek S; Little F; Celum CL; Bekker LG
J Int AIDS Soc; 2022 Jul; 25(7):e25968. PubMed ID: 35872602
[TBL] [Abstract][Full Text] [Related]
5. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
[TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis.
Bailey LE; Siberry GK; Agaba P; Douglas M; Clinkscales JR; Godfrey C
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25794. PubMed ID: 34713578
[TBL] [Abstract][Full Text] [Related]
7. "It went through the roof": an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19.
Matambanadzo P; Busza J; Mafaune H; Chinyanganya L; Machingura F; Ncube G; Steen R; Phillips A; Cowan FM
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25813. PubMed ID: 34713613
[TBL] [Abstract][Full Text] [Related]
8. Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018.
Djomand G; Bingham T; Benech I; Muthui M; Savva H; Alamo S; Manopaiboon C; Wheeler T; Mital S
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(8):212-215. PubMed ID: 32107367
[TBL] [Abstract][Full Text] [Related]
9. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
[TBL] [Abstract][Full Text] [Related]
10. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19.
Bachanas PJ; Chun HM; Mehta N; Aberle-Grasse J; Parris K; Sherlock MW; Lloyd S; Zeh C; Makwepa DK; Kapanda ML; Dokubo EK; Bonono L; Balachandra S; Ehui E; Fonjungo P; Nkoso AM; Mazibuko S; Okello VN; Tefera F; Getachew M; Katiku EM; Mulwa A; Asiimwe FM; Tarumbiswa TF; Auld AF; Nyirenda R; Dos Santos De Louvado AP; Gaspar I; Hong SY; Ashipala L; Obanubi C; Ikpeazu A; Musoni C; Yoboka E; Mthethwa S; Pinini Z; Bunga S; Rumunu J; Magesa DJ; Mutayoba B; Nelson LJ; Katureebe C; Agolory S; Mulenga LB; Nyika P; Mugurungi O; Ellerbrock T; Mitruka K
J Int AIDS Soc; 2022 Nov; 25(11):e26033. PubMed ID: 36419346
[TBL] [Abstract][Full Text] [Related]
11. Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis.
Huang YLA; Zhu W; Wiener J; Kourtis AP; Hall HI; Hoover KW
Clin Infect Dis; 2022 Aug; 75(1):e1020-e1027. PubMed ID: 35040928
[TBL] [Abstract][Full Text] [Related]
12. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
Irungu E; Khoza N; Velloza J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
[TBL] [Abstract][Full Text] [Related]
13. Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines.
Abadan SS; Hawryluk L; Montandon M; Flowers N; Schueller J; Eakle R; Patel P; Chevalier MS; Rana S; Amzel A
Glob Health Sci Pract; 2022 Dec; 10(6):. PubMed ID: 36951281
[TBL] [Abstract][Full Text] [Related]
14. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
Dunbar MS; Kripke K; Haberer J; Castor D; Dalal S; Mukoma W; Mullick S; Patel P; Reed J; Subedar H; Were D; Warren M; Torjesen K
Sex Health; 2018 Nov; 15(6):513-521. PubMed ID: 30408431
[TBL] [Abstract][Full Text] [Related]
15. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
[TBL] [Abstract][Full Text] [Related]
16. Pre-exposure Prophylaxis Discontinuation During the COVID-19 Pandemic Among Men Who Have Sex With Men in a Multisite Clinical Cohort in the United States.
Goedel WC; Rogers BG; Li Y; Nunn AS; Patel RR; Marshall BDL; Mena LA; Ward LM; Brock JB; Napoleon S; Zanowick-Marr A; Curoe K; Underwood A; Johnson CJ; Lockwood KR; Chan PA
J Acquir Immune Defic Syndr; 2022 Oct; 91(2):151-156. PubMed ID: 36094480
[TBL] [Abstract][Full Text] [Related]
17. Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision.
Henderson L; Gibbs J; Quinn J; Ramasami S; Estcourt C
Int J STD AIDS; 2022 Jun; 33(7):718-721. PubMed ID: 35465791
[TBL] [Abstract][Full Text] [Related]
18. Impact of national commissioning of pre-exposure prophylaxis (PrEP) on equity of access in England: a PrEP-to-need ratio investigation.
Coukan F; Sullivan A; Mitchell H; Jaffer S; Williams A; Saunders J; Atchison C; Ward H
Sex Transm Infect; 2024 Apr; 100(3):166-172. PubMed ID: 38508708
[TBL] [Abstract][Full Text] [Related]
19. Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020.
Fisher KA; Patel SV; Mehta N; Stewart A; Medley A; Dokubo EK; Shang JD; Wright J; Rodas J; Balachandra S; Kitenge F; Mpingulu M; García MC; Bonilla L; Quaye S; Melchior M; Banchongphanith K; Phokhasawad K; Nkanaunena K; Maida A; Couto A; Mizela J; Ibrahim J; Charles OO; Malamba SS; Musoni C; Bolo A; Bunga S; Lolekha R; Kiatchanon W; Bhatia R; Nguyen C; Aberle-Grasse J;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):447-452. PubMed ID: 35324881
[TBL] [Abstract][Full Text] [Related]
20. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
Adeagbo O; Harrison S; Qiao S; Li X
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
